Pardee Hospital is now accepting applications for the 2013 Junior Volunteer Summer Program. The Junior Volunteers provide an important service to the individuals they serve, and to the community as a whole.
In order to participate in the Junior Volunteer Summer Program, potential volunteers must be at least 14 years of age by June 1, 2013. Applicants are also required to write a brief essay explaining why they would like to participate in the Junior Volunteer Summer Program, as well as include their interests and future goals.
Completed applications and documents must be turned in by May 6. Orientation will begin on June 17, and Junior Volunteers will receive a Tuberculin Skin Test that is offered for free by Pardee Hospital.
The occurrence of diabetes and other chronic conditions in employees can be a result of many factors including age, ethnicity, family history and obesity. Medical costs associated with diabetes vary, depending on the level of overall glucose (blood sugar) control and/or the coexistence of other medical conditions, including heart disease, high blood pressure, eye disease or kidney disease.
With better control of diabetes, companies may reduce the later costs of the complications of diabetes and may be able to utilize these "cost avoidance dollars" in other areas.
Want to take the screening tool and find out more? Click here to take the screening tool.
Need Help Managing Your Diabetes?
Pardee Hospital and Mission Health announced today that a collaboration between both health care organizations and YMCA of Western North Carolina will be based onsite at the Mission Pardee Health Campus property that is currently being constructed.
Pardee, Mission and the Y plan on delivering new programming designed to offer a broad array of effective and accessible health and wellness services for the community. The Y will provide healthy living programs such as cooking classes, YMCA Diabetes Prevention Program, LIVESTRONG at the Y, group exercise classes, and a variety of additional wellness programs to support the health needs of the community.
“Whenever like-minded, community-focused organizations can partner for the sake of the community, everyone wins,” said Jay Kirby, President/CEO of Pardee Hospital. “It is more important than ever for organizations such as ours to make these valuable health and wellness services more accessible and more convenient to the people we serve.”
“The Y looks forward to expanding its service in Buncombe and Henderson County with a focus on healthy living ,” said Paul Vest, President & CEO, YMCA of Western North Carolina. “Through this partnership we will create a lasting, positive impact on the lives of families, neighbors and youth in the community. This brings us one step closer to realizing the Y’s 10 year strategic plan of building healthier communities in Western North Carolina.”
“We are very excited about this community collaboration,” said Jill Hoggard Green, PhD, RN, President of Mission Hospital and Mission Medical Associates. “Our mission is to improve the health and wellness of the people of western North Carolina and having the YMCA of Western North Carolina as a partner is a significant step toward helping make that mission a reality."
Pardee Hospital's nationally recognized Comprehensive Cancer Center has opened a prevention study to those who have had recent, surgical removal of early-stage cancerous colon polyps or tumors and who are not already taking a statin, a class of drug that lowers cholesterol.
Polyps can lead to colon cancer if left untreated, and those who have been diagnosed with cancerous polyps are at high risk for recurrence of the disease. The National Cancer Institute-sponsored study will evaluate whether the cholesterol drug Rosuvastatin (Crestor) may kill remaining tumor cells after surgery, prevent polyps from forming and/or keep colon cancer from returning.
"While major advances have been made in colon cancer treatment in recent years, we would much rather not have to treat it at all," says James Radford, M.D., principal researcher for Pardee's Cancer Research Program. "To accomplish this goal, we have to learn how to prevent it, and this study is a major step in that direction."
Colon cancer is the third most common cancer found in men and women in the United States, with more than 100,000 new cases estimated for 2013. According to the National Cancer Institute, colon cancer is highly treatable and often curable in its early stages, with surgery resulting in a cure in 50 percent of cases. But recurrence of the disease following surgery is a major problem and is often the ultimate cause of death.
The polyp prevention study, titled "P-5: Statin Polyp Prevention Trial in Patients with Resected Colon Cancer," is being conducted by the National Surgical Adjuvant Breast and Bowel Project, a network of cancer research professionals. Along with Pardee, more than 400 medical centers in North America are enrolling patients in the study.
Those interested in participating in the polyp prevention trial can call Pardee's Cancer Research Department for more information at (828) 696-4716.